ONCOREVEAL
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90980823
- Registration number
- 7347499
- Mark type
- Stylized text
- Filed
- 17 Feb 2021
- Published for opposition
- 07 Dec 2021
- Registered
- 02 Apr 2024
- Attorney of record
- Andrew T. Pettit
Goods and services
- Class 001 — Chemicals: Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research; biological and biochemical kits for scientific research, clinical research, and scientific diagnostics research
- Class 005 — Pharmaceuticals: Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical diagnostic purposes; biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer; biological and biochemical kits for medical diagnostic purposes
- Class 009 — Scientific and electric apparatus: Downloadable computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; downloadable computer software for analyzing biological samples; downloadable computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; downloadable computer software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; downloadable computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; downloadable computer software for health and wellness assessment, namely, for use in genomic analysis; downloadable computer software for genetic and bioinformatics analysis
Owner
- Pillar Biosciences, Inc., Natick, MA, US
- Pillar Biosciences, Inc., Natick, MA, US
- Pillar Biosciences, Inc., Natick, MA, US
Prosecution history
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Feb 2024 — DIVISIONAL PROCESSING COMPLETE
- 30 Jan 2024 — DIVISIONAL REQUEST RECEIVED
- 06 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jan 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 30 Oct 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Oct 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jul 2023 — NON-FINAL ACTION E-MAILED